Deerfield Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9M Sell
1,296,862
-1,406,376
-52% -$66.7M 0.6% 44
2026
Q1
$139M Buy
2,703,238
+1,197,366
+80% +$83.8M 1.65% 17
2025
Q4
$139M Buy
1,505,872
+458,178
+44% +$43.8M 1.77% 15
2025
Q3
$77.7M Buy
1,047,694
+907,694
+648% +$91.9M 1.19% 26
2025
Q2
$18.2M Buy
+140,000
New +$20.3M 0.33% 51
2024
Q3
Sell
-2,813
Closed -$376K 548
2024
Q2
$376K Buy
+2,813
New +$532K 0.01% 310
2019
Q3
Sell
-151,106
Closed -$9.16M 100
2019
Q2
$9.16M Buy
151,106
+12,106
+9% +$653K 0.33% 73
2019
Q1
$7.89M Sell
139,000
-261,781
-65% -$14.1M 0.3% 65
2018
Q4
$16.9M Buy
400,781
+211,781
+112% +$9M 0.68% 49
2018
Q3
$7.95M Buy
+189,000
New +$8.87M 0.28% 79

Other funds holding INSP

Deerfield Management's INSP Position: Q2 2026 in Review

Deerfield Management reduced its Inspire Medical Systems (INSP) stake by 52% in Q2 2026, selling an estimated $66.7M and leaving 1,296,862 shares worth $57.9M. The position accounts for 0.6% of the portfolio, ranked #44.

Deerfield Management first reported a position in INSP in Q3 2018 and has held it in 10 quarters since. The position peaked at $139M in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Deerfield Management held 1,296,862 shares of Inspire Medical Systems worth $57.9M as of Q2 2026.
  • Deerfield Management sold 1,406,376 Inspire Medical Systems shares in Q2 2026, an estimated $66.7M.
  • Inspire Medical Systems made up 0.6% of Deerfield Management's portfolio in Q2 2026, its #44 holding.
  • Deerfield Management first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 10 quarters since.
  • Deerfield Management's Inspire Medical Systems position peaked at $139M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.